Conclusion of a non-exclusive rebate agreement under Section 130a(8) of the German Social Code, Book V, for the active substance methylprednisolone, ATC D07AC14, for the period 01/06/2026 to 31/05/2028 (plus one extension option of 12 months)

Summary

The tender concerns a non-exclusive rebate agreement for the active substance methylprednisolone (ATC D07AC14) for the period 1 June 2026 to 31 May 2028, with one possible 12-month extension. It is an open accession model: DAK-Gesundheit intends to conclude contracts with as many interested pharmaceutical companies as possible. The bidder must submit an application letter, the signed contract, annexes 1 and 2, and send them by email by the deadline.